Lilly’s Experimental Weight-Loss Drug Posts Best Results Yet (3)

An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any treatment yet, another boost for the company’s efforts to dominate the burgeoning obesity drug market.

Obese patients shed an average of 24.2% of their body weight, about 58 pounds, on the highest dose of the drug after 48 weeks, according to a study released Monday by the New England Journal of Medicine. A quarter of those getting the highest dose lost 30% or more, the company-funded, mid-stage trial showed.

“We have not seen results like this before in a trial of less than one ...